2031년까지 글로벌 및 사우디아라비아 암 치료제 시장 전망

Global & Saudi Arabia Cancer Therapeutics Market to 2031

상품코드Russia Cancer Therapeutics Market.pdf
발행기관Business Market Insights
발행일2025.05.26
페이지 수100 Pages
포맷PDF
커버리지Country

₩3,600,000 – ₩6,600,000

보고서 요약(국문)

사우디아라비아의 암 치료제 시장 성장은 암 발병률 증가, 의료 인프라 개선, 그리고 고령 인구 증가에 힘입어 가속화되고 있습니다. 사우디아라비아에서는 암 발병 건수와 관련 사망률이 증가하고 있습니다. GLOBOCAN 2020에 따르면, 약 27,885건의 새로운 암 환자가 발생했으며, 2040년에는 60,429건으로 증가할 것으로 예상됩니다. "사우디아라비아 고령자의 권리와 복지" 보고서는 60세 이상 인구가 2020년 200만 명(전체 인구의 5.9%)에서 2050년 1,050만 명(23.7%)으로 5배 증가할 것으로 예측합니다. 또한, 80세 이상 인구는 2050년까지 160만 명에 달해 전체 인구의 4%를 차지할 것으로 예상됩니다. 흡연 증가와 건강하지 못한 식습관과 같은 요인들도 사우디아라비아 인구의 암 발병 위험을 높이는 요인으로 작용하고 있습니다.

사우디 정부는 의료 분야에 상당한 투자를 해왔으며, 특히 암 치료에 중점을 두고 있습니다. 비전 2030 계획은 최첨단 암 치료법에 대한 접근성 확대 등 의료 서비스 개선을 강조합니다. 킹 파이살 전문 병원 및 연구 센터와 같은 선도적인 기관들은 암 연구 및 치료의 최전선에 서서 환자들에게 첨단 치료 옵션을 제공하고 있습니다.

보고서 요약(영어 원문)

The expansion of the cancer therapeutics market in Saudi Arabia is propelled by a rising cancer incidence, enhanced healthcare infrastructure, and a growing elderly population. The country has witnessed an increase in cancer cases and related mortality rates. According to GLOBOCAN 2020, approximately 27,885 new cancer cases were reported, with projections indicating a rise to 60,429 cases by 2040. The report "Rights and Wellbeing of Older Persons in Saudi Arabia" estimates that the population aged 60 and above will increase fivefold between 2020 and 2050, growing from 2 million (5.9% of the population) to 10.5 million (23.7%). Furthermore, those aged 80 and over are expected to reach 1.6 million, accounting for 4% of the total population by 2050. Factors such as increased tobacco consumption and unhealthy dietary habits further contribute to the elevated cancer risk in the Saudi population.

The Saudi government has made substantial investments in healthcare, with a strong focus on cancer treatment. The Vision 2030 initiative emphasizes healthcare enhancements, including expanding access to cutting-edge cancer therapies. Leading institutions like the King Faisal Specialist Hospital and Research Centre are at the forefront of cancer research and treatment, providing patients with access to advanced therapeutic options.

상세 목차

TABLE OF CONTENTS

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation:

4. Saudi Arabia Cancer Therapeutics Market Landscape

4.1 Overview

4.2 Ecosystem Analysis

4.2.1 List of Vendors in the Value Chain

5. Cancer Therapeutics Market Key Market Dynamics

5.1 Cancer Therapeutics Market – Key Market Dynamics

5.2 Market Drivers

5.3 Market Restraints

5.4 Market Opportunities

5.5 Future Trends

5.6 Impact of Drivers and Restraints

6. Saudi Arabia Cancer Therapeutics Market – Analysis

6.1 Saudi Arabia Cancer Therapeutics Market Revenue (US$ Million), 2021–2031

6.2 Saudi Arabia Cancer Therapeutics Market Revenue and Forecast Analysis

7. Saudi Arabia Cancer Therapeutics Market Analysis – by Therapy Types

7.1 Saudi Arabia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types

8. Saudi Arabia Cancer Therapeutics Market Analysis – by Indications

8.1 Saudi Arabia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

9. Saudi Arabia Cancer Therapeutics Market Analysis – by Distribution Channel

9.1 Saudi Arabia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players

10.1 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.2 Partnerships and Collaborations

11.2 Other Developments

12. Company Profiles

12.1 Bristol-Myers Squibb Co

12.1. 1 Key Facts

12.1. 2 Business Description

12.1. 3 Products and Services

12.1. 4 Financial Overview

12.1. 5 SWOT Analysis

12.1. 6 Key Developments

12.2 AbbVie Inc

12.2. 1 Key Facts

12.2. 2 Business Description

12.2. 3 Products and Services

12.2. 4 Financial Overview

12.2. 5 SWOT Analysis

12.2. 6 Key Developments

12.3 Johnson & Johnson

12.3. 1 Key Facts

12.3. 2 Business Description

12.3. 3 Products and Services

12.3. 4 Financial Overview

12.3. 5 SWOT Analysis

12.3. 6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4. 1 Key Facts

12.4. 2 Business Description

12.4. 3 Products and Services

12.4. 4 Financial Overview

12.4. 5 SWOT Analysis

12.4. 6 Key Developments

12.5 Pfizer Inc

12.5. 1 Key Facts

12.5. 2 Business Description

12.5. 3 Products and Services

12.5. 4 Financial Overview

12.5. 5 SWOT Analysis

12.5. 6 Key Developments

12.6 AstraZeneca Plc

12.6. 1 Key Facts

12.6. 2 Business Description

12.6. 3 Products and Services

12.6. 4 Financial Overview

12.6. 5 SWOT Analysis

12.6. 6 Key Developments

12.7 Merck KGaA

12.7. 1 Key Facts

12.7. 2 Business Description

12.7. 3 Products and Services

12.7. 4 Financial Overview

12.7. 5 SWOT Analysis

12.7. 6 Key Developments

12.8 Novartis AG

12.8. 1 Key Facts

12.8. 2 Business Description

12.8. 3 Products and Services

12.8. 4 Financial Overview

12.8. 5 SWOT Analysis

12.8. 6 Key Developments

12.9 Astellas Pharma Inc

12.9. 1 Key Facts

12.9. 2 Business Description

12.9. 3 Products and Services

12.9. 4 Financial Overview

12.9. 5 SWOT Analysis

12.9. 6 Key Developments

12.10 Eli Lilly and Co

12.10. 1 Key Facts

12.10. 2 Business Description

12.10. 3 Products and Services

12.10. 4 Financial Overview

12.10. 5 SWOT Analysis

12.10. 6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

언급된 주요 기업들

TABLE OF COMPANIES

1. Bristol-Myers Squibb Co

2. AbbVie Inc

3. Johnson & Johnson

4. F. Hoffmann-La Roche Ltd

5. Pfizer Inc

6. AstraZeneca Plc

7. Merck KGaA

8. Novartis AG

9. Astellas Pharma Inc

10. Eli Lilly and Co

표 목록 (Tables)

TABLE OF TABLES

Table 1. Saudi Arabia Cancer Therapeutics Market Segmentation

Table 2. List of Vendors

Table 3. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)

Table 4. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 5. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types

Table 6. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types

Table 7. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 8. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 9. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 10. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 11. List of Abbreviations

그림 목록 (Figures)

TABLE OF FIGURES

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. Saudi Arabia Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031

Figure 3. Heat Map Analysis by Key Players

Figure 4. Company Positioning and Concentration